文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > IT/计算机 > 互联网 > Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative AMD
侵权投诉

Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative AMD

ActaOphthalmologica

Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative AMD

2014

Circulatinganti-retinalantibodiesinresponsetoanti-angiogenictherapyinexudativeage-relatedmaculardegeneration

1

ska,2Boz_enaRomanowska-Dixon1andMarekSanak2AgnieszkaKubicka-Trzazska,JoannaWilan

12

DepartmentofOphthalmologyandOcularOncology,JagiellonianUniversityMedicalCollege,Krakow,Poland

DivisionofMolecularBiologyandClinicalGenetics,JagiellonianUniversityMedicalCollege,Krakow,Poland

ABSTRACT.

Purpose:Todeterminechangesinanti-retinalantibodies(ARAs)duringanti-VEGFtherapyinpatientswithexudativeage-relatedmaculardegeneration(AMD)andtoassessthecorrelationsbetweenARAsanddiseaseactivity.

Methods:Thestudycomprised98patientstreatedwithintravitrealbev-acizumab.Theophthalmicexaminationincludedbestcorrectedvisualacuity(BCVA),slitlampbiomicroscopy,fundoscopy, uoresceinangiography(FA),andopticalcoherencetomography(OCT).SerumARAslevelswereassessedbyindirectimmuno uorescence(IIF)onnormalmonkeyretinasubstrate.Thesestudieswererepeatedat4weekintervalswithin8monthsofafollow-up.Theseraof50sex-andage-matchedhealthysubjectswereusedascontrols.

Results:Atbaselineexamination,94(95.5%)ofthe98patientswerepositiveforARAs.TheARAstitresweresigni cantlyhigher(p=0.0000)thanincontrols.ApositivecorrelationwasfoundbetweentitresofARAsandthediameterofchoroidalneovascularization(CNV)asmeasuredbyFA(p=0.0000),andcentralretinalthickness(CRT)assessedbyOCT(p=0.0000).ApositivecorrelationwasalsofoundbetweenthediameterofCNV,CRTandthecomplexityofcirculatingARAs.Followingtreatmentallpatientsdemonstratedsigni cantdecreaseinARAslevelsaswellasimprovementofBCVA,reductionofsubretinal uidonOCTanddecreasedleakageonFA.

Conclusion:ChangesinserumARAslevelsoccurredinparallelwithclinicaloutcomesofanti-VEGFtherapy.TreatmentreducedserumlevelsofARAs,withthegreatestreductionoccurringduringthe‘loading’phase.ThisstudydemonstratedthatARAsmayactasaserumbiomarkerofthee cacyofanti-VEGFtherapy.

Keywords:age-relatedmaculardegeneration–anti-retinalautoantibodies–anti-vascularendo-thelialgrowthfactortherapy–bevacizumab

ActaOphthalmol.

ª2014ActaOphthalmologicaScandinavicaFoundation.PublishedbyJohnWiley&SonsLtd

doi:10.1111/aos.12435

Introduction

Age-relatedmaculardegeneration(AMD)istheleadingcauseofblindnessinpeopleovertheageof50yearsindevelopedcountries.Despiteextensive

experimentalandclinicalstudies,itspathogenesisisstillnotfullyunder-stood(Fineetal.2000).However,thereisgrowingevidencethatautoim-munityagainstretinalantigensmight

beinvolvedinthediseaseprocess(Karlstetter&Langmann2012;Yuetal.2012;Whitcupetal.2013).Ithasbeenknownthatoculardiseasesinwhichin ammatoryandautoimmunecomponentsplayanimportantrole,maybeassociatedwiththepresenceofcirculatingARAs.SeveralstudieshaveshownthatARAsarepresentintheseraofpatientswithexudativeAMD(Penfoldetal.1990;Gurneetal.1991;Pateletal.2005;Cherepano etal.2006;Joachimetal.2007;Kubicka- ska2009;Kubicka-Trzazska&WilanTrzazskaetal.2012).Thepreciseroleoftheseantibodiesinthediseaseprocessisunclear.IthasbeensuggestedthatcirculatingARAsmaybeanepiphe-nomenondevelopinginresponsetoretinaldamageoralternatively,theycouldbeinvolvedinthepathogenesisofAMD(Penfoldetal.1990;Gurneetal.1991;Pateletal.2005).

AlthoughthepresenceofserumARAsinpatientswithAMDisthoughttobeasigni cantdiseasemarker,toourknowledgenodataonthebehaviourofcirculatingARAsinresponsetoanti-VEGFtherapyiscur-rentlyavailable.Theaimofthisstudywastoassessthepresenceandpro leofserumARAsinpatientswithexu-dativeAMD,andtoestablishthecorrelationsbetweentheimmuno uo-rescencepatternsandlevelsofARAs,anddiseaseactivity.ThesecondaimwastodeterminechangesinARAsduringintravitrealbevacizumabther-apyandtoassessthecorrelationsbetweencirculatingARAsandthecharacteristicsofdiseaseactivity,

1

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email